The latest news......
EMA starts Review Tavneos®
The current review is a so called Article 20 non-pharmacovigilance procedure. This type of procedure is used when questions arise about the scientific basis or robustness of the data that supported the original approval of a medicine.
It is not started because of new safety problems or concerns about side effects for patients.
Review Patient Summit 2025
In November, patients, caregivers, clinicians and researchers from more than a dozen European countries met in Prague for the 2025 European Vasculitis Patient Summit.
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis.
A landmark review in Nature Reviews Rheumatology calls for a new, integrated approach to ANCA-associated vasculitis.When diagnosis, classification, biomarkers and patient experience come together, care becomes truly personal — and outcomes improve.
patients
Find Patient Advocacy Groups (VPAGs)
hospitals
Find vasculitis expertise
projects
Find out about the projects we are working on.